JPH10511962A - 婦人科疾患の治療または予防用の医薬組成物の製造への３，４−ジフェニルクロマンの使用 - Google Patents

婦人科疾患の治療または予防用の医薬組成物の製造への３，４−ジフェニルクロマンの使用

Info

Publication number
JPH10511962A
JPH10511962A JP8521378A JP52137896A JPH10511962A JP H10511962 A JPH10511962 A JP H10511962A JP 8521378 A JP8521378 A JP 8521378A JP 52137896 A JP52137896 A JP 52137896A JP H10511962 A JPH10511962 A JP H10511962A
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
compound
lower alkoxy
independently hydrogen
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8521378A
Other languages
English (en)
Japanese (ja)
Inventor
ウィリアム エドワーズ，マーチン
ロバートソン ピゴット，ジェイムス
モハン ラブロー，ビレンダー
プラカシュ カンボジェイ，ベド
レイ，スプラブハット
コースガード，ニールス
シャルミ，ミシェル
ヒョート グルドハマー，ビルギッテ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of JPH10511962A publication Critical patent/JPH10511962A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP8521378A 1995-01-13 1996-01-10 婦人科疾患の治療または予防用の医薬組成物の製造への３，４−ジフェニルクロマンの使用 Pending JPH10511962A (ja)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
DK4695 1995-01-13
DK0046/95 1995-01-13
DK0048/95 1995-01-13
DK0045/95 1995-01-13
DK4795 1995-01-13
DK4595 1995-01-13
DK4895 1995-01-13
DK0047/95 1995-01-13
DK4495 1995-01-13
DK0044/95 1995-01-13
DK0769/95 1995-06-30
DK76995 1995-06-30
DK77295 1995-06-30
DK76895 1995-06-30
DK0768/95 1995-06-30
DK77095 1995-06-30
DK0770/95 1995-06-30
DK0772/95 1995-06-30
DK0771/95 1995-06-30
DK77195 1995-06-30
PCT/DK1996/000015 WO1996021444A1 (en) 1995-01-13 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of gynaecological disorders

Publications (1)

Publication Number Publication Date
JPH10511962A true JPH10511962A (ja) 1998-11-17

Family

ID=27579214

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8521378A Pending JPH10511962A (ja) 1995-01-13 1996-01-10 婦人科疾患の治療または予防用の医薬組成物の製造への３，４−ジフェニルクロマンの使用

Country Status (11)

Country Link
EP (1) EP0804190A1 (hu)
JP (1) JPH10511962A (hu)
CN (1) CN1168096A (hu)
AU (1) AU693628B2 (hu)
CA (1) CA2208861A1 (hu)
CZ (1) CZ212297A3 (hu)
HU (1) HUP9702244A3 (hu)
IL (1) IL116746A0 (hu)
MX (1) MX9705219A (hu)
NO (1) NO973243L (hu)
WO (1) WO1996021444A1 (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043269A (en) * 1996-10-28 2000-03-28 Novo Nordisk A/S cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5919817A (en) * 1996-10-28 1999-07-06 Novo Nordisk A/S Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
EP0934297A1 (en) * 1996-10-28 1999-08-11 Novo Nordisk A/S NOVEL $i(cis)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
CA2270111A1 (en) * 1996-10-28 1998-05-07 Lise Brown Christiansen Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
CA2270113A1 (en) * 1996-10-28 1998-05-07 Poul Jacobsen Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
DE69717843T2 (de) * 1996-10-28 2003-09-25 Novo Nordisk As Cis-3,4-chromanderivate zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen
EP0934299A1 (en) * 1996-10-28 1999-08-11 Novo Nordisk A/S NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
US5994390A (en) * 1996-10-28 1999-11-30 Novo Nordisk Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US6316494B1 (en) 1996-10-28 2001-11-13 Novo Nordisk A/S cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5958967A (en) * 1996-10-28 1999-09-28 Novo Nordisk A/S Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129623A0 (en) * 1996-10-28 2000-02-29 Novo Nordisk As Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979644B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
DK0937062T3 (da) * 1996-10-28 2003-04-07 Novo Nordisk As Nye cis-3,4-chroman-derivater, der er nyttige i forebyggelsen eller behandlingen af østrogen-relaterede sygdomme eller syndromer
AU4772197A (en) * 1996-10-28 1998-05-22 Novo Nordisk A/S Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5985306A (en) * 1996-10-28 1999-11-16 Novo Nordisk A/S (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
EP1282615B1 (en) 2000-03-01 2011-10-19 N.V. Organon Chroman derivatives as estrogenic compounds
EP2407462B1 (en) 2004-09-21 2014-07-30 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
CA2816319C (en) 2010-11-01 2020-06-30 Marshall Edwards, Inc. Isoflavonoid compounds and methods for the treatment of cancer
PT2953938T (pt) 2014-02-07 2017-10-09 Novogen ltd Compostos de benzopirano funcionais e sua utilização
PT3253208T (pt) 2015-02-02 2021-06-17 The Spanish National Cancer Res Centre Terapêuticas de combinação para utilização no tratamento do cancro da mama

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
MX9705219A (es) 1997-10-31
IL116746A0 (en) 1996-05-14
CN1168096A (zh) 1997-12-17
NO973243D0 (no) 1997-07-11
AU693628B2 (en) 1998-07-02
HUP9702244A3 (en) 1999-12-28
CZ212297A3 (en) 1997-11-12
EP0804190A1 (en) 1997-11-05
CA2208861A1 (en) 1996-07-18
HUP9877967A2 (en) 1998-12-28
AU4329396A (en) 1996-07-31
WO1996021444A1 (en) 1996-07-18
NO973243L (no) 1997-07-11

Similar Documents

Publication Publication Date Title
JPH10511962A (ja) 婦人科疾患の治療または予防用の医薬組成物の製造への３，４−ジフェニルクロマンの使用
CA2157879C (en) Methods for inhibiting bone loss with 3,4-diarylchroman
JP2000506508A (ja) 良性前立腺肥大の治療又は予防のための医薬組成物の製造のための３，４―ジフェニルクロマンの使用
US5747059A (en) Atrophy of skin/mucous membrane
US5883118A (en) Prostatic carcinoma
JPH07215871A (ja) 血清コレステロールを減少させるための方法
JP2000506505A (ja) 閉経期の症状の治療又は予防のための医薬組成物の製造のための３，４―ジフェニルクロマンの使用
JPH10511961A (ja) 高リポプロテイン血症、高トリグリセリド血症、高脂血症又は高コレステロール血症の治療又は予防のための、又は抗血液凝固処置のための医薬組成物の製造のための３，４−ジフェニル・クロマンの使用
JPH10512270A (ja) 肥満の治療又は予防のための医薬製剤の製造のための３，４−ジフェニル・クロマンの使用
US5780502A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
JPH10513154A (ja) 血管拡張治療または予防用の医薬組成物の製造への３，４−ジフェニルクロマンの使用
JP2000514441A (ja) 月経前症候群の１又は複数の症状を抑制するための医薬組成物の製造のための３，４―ジフェニルクロマンの使用
JPH10511960A (ja) 特発性の又は生理学的な女性化乳房の治療又は予防のための医薬製剤の製造のための３，４−ジフェニル・クロマンの使用
MXPA97005219A (en) Use of 3,4-difenil-chromanos for the manufacture of a pharmaceutical composition for the treatment of profilaxis of disorders ginecologi
KR19980701383A (ko) 부인병 질환의 치료 또는 예방용 약학적 조성물의 제조를 위한 3,4-디페닐크로만의 사용(use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia)
MXPA97005218A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de ginecomastia idiopatica o fisiologica
MXPA97005214A (en) Use of the 3,4-difenil-chromanos for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinemia, hypertriglyceridemia, hyperlipidemia or hypercholesterolemia or arterioesclerosis or for anti-treatment